Trial intelligence / Profile preview

Effect of injectable articular cartilage in the repair of chondral defects

TCTR20250909012Phase 2Not yet recruiting

Sponsor
EpiBone
Start
Jan 2026
Countries
1
01

Overview

Phase 2 trial in chondral defect and cartilage defect, sponsored by EpiBone. Planned start Jan 2026; status: not yet recruiting.

02

Conditions

chondral defectcartilage defect

Beyond the preview

Go deeper on TCTR20250909012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250909012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call